Therefore, we hypothesized that blocking JAK/STAT pathway with JAK inhibitor could be useful in mitigating SAg-induced CRS as in certain human inflammatory diseases, malignancies, or experimental candida sepsis (27, 28, 30–33). The gene discussed is SOAT1; the disease is congenital rubella syndrome.